1 – 7 of 7
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
- Adjuvant imatinib for GIST : duration likely matters
- 2018
- The management and survival outcomes of nasopharyngeal cancer in the Nordic countries*
- Bone sarcomas : ESMO-PaedCan-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up
- Gastrointestinal stromal tumours : ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up
- 2012
-
Adjuvant therapy in primary GIST: state-of-the-art
Reichardt, P. ; Blay, J. -Y. ; Boukovinas, I. ; Brodowicz, T. ; Broto, J. M. ; Casali, P. G. ; Decatris, M. ; Eriksson, Mikael LU
; Gelderblom, H.
and Kosmidis, P.
, et al.
(2012)
In Annals of Oncology
23(11).
p.2776-2781
Mark
- 2005
- Cleavable ErbB4 isoform in estrogen receptor-regulated growth of breast cancer cells
- 2004
- Skin toxicity as a risk factor for major infections in breast cancer patients treated with docetaxel